lactic acid has been researched along with 3-methyladenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Dong, Y; Feng, SS; Jiang, Y; Li, X; Liang, X; Mei, L; Tao, W; Zeng, X; Zhang, X | 1 |
| Bastos, ML; Carvalho, F; Carvalho, RA; Costa, VM; Gomes, AS; Pinto, M; Reis-Mendes, A; Remião, F; Sousa, E | 1 |
2 other study(ies) available for lactic acid and 3-methyladenine
| Article | Year |
|---|---|
The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment.
Topics: Adenine; Animals; Autophagy; Cell Line, Tumor; Chloroquine; Drug Delivery Systems; Female; Humans; Immunoblotting; Lactic Acid; Mice, SCID; Nanomedicine; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Xenograft Model Antitumor Assays | 2014 |
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Topics: Adenine; Adenosine Triphosphate; Animals; Antineoplastic Agents; Autophagy; Cardiotoxicity; Cell Line; Dose-Response Relationship, Drug; Lactic Acid; Membrane Potential, Mitochondrial; Mitoxantrone; Myocytes, Cardiac; Quinoxalines; Rats; Time Factors | 2017 |